• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Verona Pharma Plc ADR (NQ: VRNA )

    22.15 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 25, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 22.15
    Bid (Size) 22.00 (1)
    Ask (Size) 23.49 (1)
    Prev. Close 22.15
    Today's Range 22.15 - 22.15
    52wk Range 11.39 - 23.72
    Shares Outstanding 480,291,822
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    First Inhaled COPD Therapy In Over 2 Decades - FDA Approves Verona Pharma's First Commercial Product
    The FDA has approved Verona Pharma's Ohtuvayre (ensifentrine) as maintenance treatment of chronic obstructive pulmonary disease in adults. The drug could generate $3.6 billion in peak sales. 
    Via Benzinga
    Exposures Product Safety
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga

    Performance

    YTD
    +17.76%
    +17.76%
    1 Month
    +47.27%
    +47.27%
    3 Month
    +44.68%
    +44.68%
    6 Month
    +23.88%
    +23.88%
    1 Year
    +9.71%
    +9.71%

    More News

    Read More
    5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More
    Via Benzinga
    Tesla, Nvidia, John Wiley & Sons And Other Big Stocks Moving Higher On Thursday
    Via Benzinga
    Earnings Scheduled For February 29, 2024
    Via Benzinga
    Earnings Preview For Verona Pharma
    Via Benzinga
    Expert Ratings for Verona Pharma
    Via Benzinga
    Earnings Scheduled For August 3, 2023
    Via Benzinga
    Why It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks
    Via Investor's Business Daily
    VRNA Stock Earnings: Verona Pharma Misses EPS for Q1 2024
    Via InvestorPlace
    3 Healthcare Stocks That Have Outperformed Nvidia Since 2022
    Via The Motley Fool
    3 Stocks That Could Be Monster Winners in 2024
    Via The Motley Fool
    Verona Pharma's Promising COPD Treatment Puts It in GSK's Acquisition Crosshairs, Analysts Predict Big Moves
    Via Benzinga
    4 Analysts Have This to Say About Verona Pharma
    Via Benzinga
    Earnings Preview For Verona Pharma
    Via Benzinga
    If You Invested $100 In This Stock 5 Years Ago, You Would Have $200 Today
    Via Benzinga
    Why RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Week In Review: Suzhou Duality Out-Licenses Two ADCs To BioNTech In $1.7 Billion Deal
    Via Talk Markets
    Charles Schwab To Rally Over 19%? Here Are 10 Other Analyst Forecasts For Monday
    Via Benzinga
    Earnings Scheduled For November 2, 2023
    Via Benzinga
    Earnings Scheduled For May 9, 2023
    Via Benzinga
    7 Biotech Stocks That Could Be the Next Big Thing
    Via InvestorPlace
    PDS Biotechnology, Pulmonx, Tesla And Some Other Big Stocks Moving Lower On Tuesday
    Via Benzinga
    Why These 7 Healthcare Stocks Could Soar in 2023
    Via InvestorPlace
    20 Favorite Biotech & Medical Stocks For 2023
    Via Talk Markets
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.